Learn something new, network, and be surprised...
The ADAA conference brings together leading clinicians and researchers to present sessions and posters on treatments and potential cures of anxiety, depression, and co-occurring disorders. ADAA's conference provides early career and student opportunities to present their work and be awarded for their efforts.
The Therapeutic Pipeline is a new submission type which provides researchers the opportunity to highlight novel therapies under exploration.
|08/15/2022||Conference Awards, Poster, And Therapeutic Pipeline Portal Open
|08/15/2022 - 02/9/2023||Conference Registration Open - Register Early for the Best Rates
|12/07/2022||Conference Submissions Portal Closes for Poster Submissions and Therapeutic Pipeline reports
Renaissance Washington, Downtown DC - 999 Ninth Street NW, Washington. DC 20001
Have questions? Please email: [email protected].
The Renaissance Washington, Downtown DC serves as the official ADAA 2023 Annual Conference hotel.
There is a discounted ADAA room rate for conference attendees of $229.00++ per night, plus applicable taxes. Please reserve your hotel accommodations early to receive the special ADAA rate.
This rate is available through March 20, 2023, or until the room block is full.
Collaborating with ADAA at our annual conference gives your organization an opportunity to reach ADAA’s vast network of psychiatrists, social workers, psychologists, counselors, researchers, and therapists before, during and after the conference. Invest in improving mental health while growing your customer relationships.
Meet the ADAA 2023 Conference Co-Chairs
ADAA Conference Awards Program (CDLP & Klein Early Career Investigator Award)
Applications for ADAA Conference Awards Programs open.
Rogers Behavioral Health is a leading provider of evidence-based mental health services nationwide. Rogers provides inpatient, residential, and outpatient care for adults, children, and teens with depression and mood disorders, eating disorders, addiction, OCD and anxiety disorders, PTSD, and mental health disorders in kids with autism. Learn more at rogersbh.org.
VistaGen Therapeutics is developing new generation medications for multiple mental health and neurology markets where current treatments are inadequate to meet the growing needs of millions of patients worldwide. Looking beyond the limitations of current treatments for anxiety, depression and suicidal ideation, VistaGen's pipeline includes three differentiated, late-stage new drug candidates, AV-101, PH10 and PH94B, each with an exceptional safety profile and fast-acting potential to treat these debilitating diseases and disorders. VistaGen is committed to improving mental health by raising awareness of the conditions that affect the daily lives of millions of patients around the world and to introducing novel treatment alternatives into inadequate treatment paradigm
Established in 1987, the American Foundation for Suicide Prevention is dedicated to saving lives and bringing hope to those affected by suicide. AFSP creates a culture that’s smart about mental health through education and community programs, develops suicide prevention through research and advocacy, and provides support for those affected by suicide.
McLean Hospital offers exceptional care for children and adults who are living with depression and anxiety, including OCD. A top-rated hospital by U.S. News & World Report, compassionate care at McLean is provided using evidence-based treatment methods through short-term inpatient, diagnostically-specific residential, day treatment and intensive outpatient programs.
Mountain Valley Treatment Center provides clinically intensive residential treatment to teenagers and emerging adults struggling with severe Anxiety, Obsessive Compulsive, and related disorders. Mountain Valley is committed to providing empirically supported treatment with a specific focus on Exposure based Cognitive Behavioral Therapy.
Skyland Trail is a nationally recognized nonprofit mental health treatment organization located in Atlanta offering evidence-based primary psychiatric residential treatment and day treatment programs for adults and adolescents.